Cargando…

In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody

With the aim of developing an effective cancer immunotherapy for common epithelial cancer, a new class of bifunctional antibody (BFA) was developed; one arm of this BFA recognized c‐erbB‐2 gene product, and the other arm recognized CD3ɛ, a T‐cell specific surface antigen. Application of this BFA wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Yoshihiro, Aihara, Miki, Shibamori, Masafumi, Deguchi, Kyohei, Imagawa, Kenichi, Kikuchi, Mikio, Momota, Hiroshi, Azuma, Takachika, Okada, Hidechika, Alper, Özge, Hitomi, Jiro, Yamaguchi, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918874/
https://www.ncbi.nlm.nih.gov/pubmed/1353752
http://dx.doi.org/10.1111/j.1349-7006.1992.tb00126.x
_version_ 1783317510889668608
author Sugiyama, Yoshihiro
Aihara, Miki
Shibamori, Masafumi
Deguchi, Kyohei
Imagawa, Kenichi
Kikuchi, Mikio
Momota, Hiroshi
Azuma, Takachika
Okada, Hidechika
Alper, Özge
Hitomi, Jiro
Yamaguchi, Ken
author_facet Sugiyama, Yoshihiro
Aihara, Miki
Shibamori, Masafumi
Deguchi, Kyohei
Imagawa, Kenichi
Kikuchi, Mikio
Momota, Hiroshi
Azuma, Takachika
Okada, Hidechika
Alper, Özge
Hitomi, Jiro
Yamaguchi, Ken
author_sort Sugiyama, Yoshihiro
collection PubMed
description With the aim of developing an effective cancer immunotherapy for common epithelial cancer, a new class of bifunctional antibody (BFA) was developed; one arm of this BFA recognized c‐erbB‐2 gene product, and the other arm recognized CD3ɛ, a T‐cell specific surface antigen. Application of this BFA with human peripheral blood lymphocytes exhibited specific anti‐tumor activity in vitro on a breast tumor cell line, ZR‐75–1, which expressed abundant c‐erbB‐2 gene product on its cell surface. These results indicate that BFA recognizing an oncogene product on cell surface is a potential new agent for cancer immunotherapy.
format Online
Article
Text
id pubmed-5918874
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59188742018-05-11 In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody Sugiyama, Yoshihiro Aihara, Miki Shibamori, Masafumi Deguchi, Kyohei Imagawa, Kenichi Kikuchi, Mikio Momota, Hiroshi Azuma, Takachika Okada, Hidechika Alper, Özge Hitomi, Jiro Yamaguchi, Ken Jpn J Cancer Res Rapid Communication With the aim of developing an effective cancer immunotherapy for common epithelial cancer, a new class of bifunctional antibody (BFA) was developed; one arm of this BFA recognized c‐erbB‐2 gene product, and the other arm recognized CD3ɛ, a T‐cell specific surface antigen. Application of this BFA with human peripheral blood lymphocytes exhibited specific anti‐tumor activity in vitro on a breast tumor cell line, ZR‐75–1, which expressed abundant c‐erbB‐2 gene product on its cell surface. These results indicate that BFA recognizing an oncogene product on cell surface is a potential new agent for cancer immunotherapy. Blackwell Publishing Ltd 1992-06 /pmc/articles/PMC5918874/ /pubmed/1353752 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00126.x Text en
spellingShingle Rapid Communication
Sugiyama, Yoshihiro
Aihara, Miki
Shibamori, Masafumi
Deguchi, Kyohei
Imagawa, Kenichi
Kikuchi, Mikio
Momota, Hiroshi
Azuma, Takachika
Okada, Hidechika
Alper, Özge
Hitomi, Jiro
Yamaguchi, Ken
In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title_full In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title_fullStr In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title_full_unstemmed In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title_short In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
title_sort in vitro anti‐tumor activity of anti‐c‐erbb‐2 × anti‐cd3ɛ bifunctional monoclonal antibody
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918874/
https://www.ncbi.nlm.nih.gov/pubmed/1353752
http://dx.doi.org/10.1111/j.1349-7006.1992.tb00126.x
work_keys_str_mv AT sugiyamayoshihiro invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT aiharamiki invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT shibamorimasafumi invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT deguchikyohei invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT imagawakenichi invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT kikuchimikio invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT momotahiroshi invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT azumatakachika invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT okadahidechika invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT alperozge invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT hitomijiro invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody
AT yamaguchiken invitroantitumoractivityofanticerbb2anticd3ɛbifunctionalmonoclonalantibody